Bruker (BRKR) Tops Q3 EPS by 14c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BRKR Hot Sheet
Price: $63.79 +12.90%
Financial Fact:
Total cost of revenue: 208.7M
Today's EPS Names:
CIX, ARIS, COHR, More
Financial Fact:
Total cost of revenue: 208.7M
Today's EPS Names:
CIX, ARIS, COHR, More
Join SI Premium – FREE
Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.56, $0.14 better than the analyst estimate of $0.42. Revenue for the quarter came in at $874 million versus the consensus estimate of $865.19 million.
GUIDANCE:
Bruker sees FY2026 EPS of $2.10-$2.15, versus the consensus of $2.12. Bruker sees FY2026 revenue of $3.52-3.56 billion, versus the consensus of $3.556 billion.
For earnings history and earnings-related data on Bruker (BRKR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viemed Healthcare, Inc. (VMD) Misses Q3 EPS by 2c; updates guidance
- North American Construction (NOA) Misses Q3 EPS by 27c; Offers Guidance
- Steris (STE) Tops Q3 EPS by 26c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
